Marken, a clinical logistics organization, has entered into an exclusive agreement with OnAsset Intelligence Inc. to use its GPS tracking device on key shipments to improve real-time, track and trace capability through custom-designed software.
 
Marken will offer a continuous, shipment-specific device, which will track the location of each shipment in real time, as well as report its temperature, motion and shock, light exposure (open box), atmospheric pressure and remaining battery life. Marken will also offer geo-fencing at all airports and can customize geo-fence waypoints and status updates for each validated shipping lane. The device transmits in real time and communicates through customized cloud based software. 
 
Marken’s chief executive officer, Wes Wheeler, said, “Marken believes that by offering this state-of-the-art tracking device, we have taken an important and necessary step which guarantees the safe delivery of each drug shipment. Marken is committed to providing the latest technology available, and we believe we have found it with OnAsset. Our agreement with OnAsset also comes at an important time in our industry, where GDP compliance is becoming a mandate in our industry.  It also allows us to comply with recent updates to Annex 15 in Europe.”